256 related articles for article (PubMed ID: 36046787)
41. 'Luteal coasting' after GnRH agonist trigger - individualized, HCG-based, progesterone-free luteal support in 'high responders': a case series.
Kol S; Breyzman T; Segal L; Humaidan P
Reprod Biomed Online; 2015 Dec; 31(6):747-51. PubMed ID: 26507279
[TBL] [Abstract][Full Text] [Related]
42. The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a down-regulation protocol and luteal support with progesterone.
Herman A; Raziel A; Strassburger D; Soffer Y; Bukovsky I; Ron-El R
Hum Reprod; 1996 Jul; 11(7):1552-7. PubMed ID: 8671503
[TBL] [Abstract][Full Text] [Related]
43. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.
Orvieto R
J Ovarian Res; 2015 Nov; 8():69. PubMed ID: 26536862
[TBL] [Abstract][Full Text] [Related]
44. GnRHa to trigger final oocyte maturation: a time to reconsider.
Humaidan P; Papanikolaou EG; Tarlatzis BC
Hum Reprod; 2009 Oct; 24(10):2389-94. PubMed ID: 19608565
[TBL] [Abstract][Full Text] [Related]
45. GnRH Agonist and hCG (Dual Trigger) Versus hCG Trigger for Final Oocyte Maturation in Expected Normal Responders With a High Immature Oocyte Rate: Study Protocol for a Randomized, Superiority, Parallel Group, Controlled Trial.
Yan MH; Cao JX; Hou JW; Jiang WJ; Wang DD; Sun ZG; Song JY
Front Endocrinol (Lausanne); 2022; 13():831859. PubMed ID: 35418945
[TBL] [Abstract][Full Text] [Related]
46. GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles-A Systematic PRISMA Review and Meta-analysis.
Haahr T; Roque M; Esteves SC; Humaidan P
Front Endocrinol (Lausanne); 2017; 8():116. PubMed ID: 28638367
[TBL] [Abstract][Full Text] [Related]
47. New algorithm for OHSS prevention.
Papanikolaou EG; Humaidan P; Polyzos N; Kalantaridou S; Kol S; Benadiva C; Tournaye H; Tarlatzis B
Reprod Biol Endocrinol; 2011 Nov; 9():147. PubMed ID: 22054506
[TBL] [Abstract][Full Text] [Related]
48. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; Aboulfoutouh I; Khattab SM; van Wely M
Cochrane Database Syst Rev; 2011 Jan; (1):CD008046. PubMed ID: 21249699
[TBL] [Abstract][Full Text] [Related]
49. Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol.
Griesinger G; Verweij PJ; Gates D; Devroey P; Gordon K; Stegmann BJ; Tarlatzis BC
PLoS One; 2016; 11(3):e0149615. PubMed ID: 26950065
[TBL] [Abstract][Full Text] [Related]
50. Repeated GnRH agonist doses for luteal support: a proof of concept.
Wiser A; Klement AH; Shavit T; Berkovitz A; Koren RR; Gonen O; Amichay K; Shulman A
Reprod Biomed Online; 2019 Nov; 39(5):770-776. PubMed ID: 31628035
[TBL] [Abstract][Full Text] [Related]
51. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; van Wely M
Cochrane Database Syst Rev; 2010 Nov; (11):CD008046. PubMed ID: 21069701
[TBL] [Abstract][Full Text] [Related]
52. Investigation of luteal HCG supplementation in GnRH-agonist-triggered fresh embryo transfer cycles: a randomized controlled trial.
Svenstrup L; Möller S; Fedder J; Pedersen DE; Erb K; Andersen CY; Humaidan P
Reprod Biomed Online; 2024 May; 48(5):103415. PubMed ID: 38452605
[TBL] [Abstract][Full Text] [Related]
53. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study.
European Recombinant LH Study Group
J Clin Endocrinol Metab; 2001 Jun; 86(6):2607-18. PubMed ID: 11397861
[TBL] [Abstract][Full Text] [Related]
54. Gonadotropin-releasing hormone agonist triggering of oocyte maturation in assisted reproductive technology cycles.
Türkgeldi E; Türkgeldi L; Seyhan A; Ata B
Turk J Obstet Gynecol; 2015 Jun; 12(2):96-101. PubMed ID: 28913051
[TBL] [Abstract][Full Text] [Related]
55. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles.
Lanzone A; Fulghesu AM; Villa P; Guida C; Guido M; Nicoletti MC; Caruso A; Mancuso S
Fertil Steril; 1994 Jul; 62(1):35-41. PubMed ID: 8005301
[TBL] [Abstract][Full Text] [Related]
56. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
[TBL] [Abstract][Full Text] [Related]
57. GnRHa trigger and luteal coasting: a new approach for the ovarian hyperstimulation syndrome high-risk patient?
Lawrenz B; Humaidan P; Kol S; Fatemi HM
Reprod Biomed Online; 2018 Jan; 36(1):75-77. PubMed ID: 29102428
[TBL] [Abstract][Full Text] [Related]
58. The direct and indirect effects of kisspeptin-54 on granulosa lutein cell function.
Owens LA; Abbara A; Lerner A; O'floinn S; Christopoulos G; Khanjani S; Islam R; Hardy K; Hanyaloglu AC; Lavery SA; Dhillo WS; Franks S
Hum Reprod; 2018 Feb; 33(2):292-302. PubMed ID: 29206944
[TBL] [Abstract][Full Text] [Related]
59. Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control study.
Lewit N; Kol S; Manor D; Itskovitz-Eldor J
Hum Reprod; 1996 Jul; 11(7):1399-402. PubMed ID: 8671474
[TBL] [Abstract][Full Text] [Related]
60. Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders.
Griffin D; Benadiva C; Kummer N; Budinetz T; Nulsen J; Engmann L
Fertil Steril; 2012 Jun; 97(6):1316-20. PubMed ID: 22480822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
